Can (immune and other) gene expression help us to treat depression?

Alcocer-Gómez, 2014, NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder, Brain Behav. Immun., 36, 111, 10.1016/j.bbi.2013.10.017 Azrad, 2019, The TSPO ligands 2-Cl-MGV-1, MGV-1, and PK11195 differentially suppress the inflammatory response of BV-2 microglial cell to LPS, Int. J. Mol. Sci., 20, 594, 10.3390/ijms20030594 Belmaker, 2008, Major depressive disorder, N. Engl. J. Med., 358, 55, 10.1056/NEJMra073096 Belzeaux, 2014, Longitudinal monitoring of the serotonin transporter gene expression to assess major depressive episode evolution, Neuropsychobiology, 70, 220, 10.1159/000368120 Breitfeld, 2017, Gene expression and proliferation biomarkers for antidepressant treatment resistance, Transl. Psychiatry, 7, 10.1038/tp.2017.16 Cattaneo, 2013, Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets, Neuropsychopharmacology, 38, 377, 10.1038/npp.2012.191 Cattaneo, 2020, Whole-blood expression of inflammasome- and glucocorticoid-related mRNAs correctly separates treatment-resistant depressed patients from drug-free and responsive patients in the BIODEP study, Transl. Psychiatry, 10, 232, 10.1038/s41398-020-00874-7 Choi, 2011, Translocator protein (18 kDa)/peripheral benzodiazepine receptor specific ligands induce microglia functions consistent with an activated state, Glia, 59, 219, 10.1002/glia.21091 Chopra, 2011, Pathobiological targets of depression, Expert Opin. Ther. Targets, 15, 379, 10.1517/14728222.2011.553603 Clarke, 2010, Association of the 5- HTTLPR genotype and unipolar depression: a meta-analysis, Psychol. Med., 40, 1767, 10.1017/S0033291710000516 Dwyer, 2018, Machine learning approaches for clinical psychology and psychiatry, Annu. Rev. Clin. Psychol., 14, 91, 10.1146/annurev-clinpsy-032816-045037 Ferguson, 2001, SSRI antidepressant medications: adverse effects and tolerability, Prim. Care Companion J. Clin. Psychiatry, 3, 22, 10.4088/PCC.v03n0105 Gelenberg, 2010, American Psychiatric Association practice guidelines for the treatment of patients with major depressive disorder, Am. J. Psychiatr., 167, 9 Gut, 2015, Lost in translocation: the functions of the 18-kD translocator protein, Trends Endocrinol. Metabol., 26, 349, 10.1016/j.tem.2015.04.001 Hennings, 2015, RNA expression profiling in depressed patients suggests retinoid-related orphan receptor alpha as a biomarker for antidepressant response, Transl. Psychiatry, 5, e538, 10.1038/tp.2015.9 Inestrosa, 2010, Emerging roles of Wnts in the adult nervous system, Nat. Rev. Neurosci., 11, 77, 10.1038/nrn2755 Iwata, 2013, The inflammasome: pathways linking psychological stress, depression, and systemic illnesses, Brain Behav. Immun., 31, 105, 10.1016/j.bbi.2012.12.008 James, 2018, Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017, Lancet, 392, 1789, 10.1016/S0140-6736(18)32279-7 Karg, 2011, The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation, Arch. Gen. Psychiatr., 68, 444, 10.1001/archgenpsychiatry.2010.189 Karlstetter, 2014, Translocator protein (18 kDa)(TSPO) is expressed in reactive retinal microglia and modulates microglial inflammation and phagocytosis, J. Neuroinflammation, 11, 1, 10.1186/1742-2094-11-3 Kim, 2015, Translocator protein 18 kDa (TSPO): old dogma, new mice, new structure, and new questions for neuroprotection, Neural Regen Res, 10, 878, 10.4103/1673-5374.158338 Lesch, 2001, Serotonergic gene expression and depression: implications for developing novel antidepressants, J. Affect. Disord., 62, 57, 10.1016/S0165-0327(00)00351-7 Liew, 2006, The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool, J. Lab. Clin. Med., 147, 126, 10.1016/j.lab.2005.10.005 Lin, 2018, A deep learning approach for predicting antidepressant response in major depression using clinical and genetic biomarkers, Front. Psychiatr., 9, 290, 10.3389/fpsyt.2018.00290 Mehta, 2010, Gene expression studies in major depression, Curr. Psychiatr. Rep., 12, 135, 10.1007/s11920-010-0100-3 Menke, 2012, Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients, Neuropsychopharmacology, 37, 1455, 10.1038/npp.2011.331 Nettis, 2020, PET imaging shows no changes in TSPO brain density after IFN-α immune challenge in healthy human volunteers, Transl. Psychiatry, 10, 89, 10.1038/s41398-020-0768-z Nettis, 2021, Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial, Neuropsychopharmacology, 46, 939, 10.1038/s41386-020-00948-6 Niraula, 2018, Corticosterone production during repeated social defeat causes monocyte mobilization from the bone marrow, glucocorticoid resistance, and neurovascular adhesion molecule expression, J. Neurosci. : the official journal of the Society for Neuroscience, 38, 2328, 10.1523/JNEUROSCI.2568-17.2018 Penninx, 2013, Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile, BMC Med., 11, 129, 10.1186/1741-7015-11-129 Pitharouli, 2021, Elevated C-reactive protein in patients with depression, independent of genetic, health, and psychosocial factors: results from the UK biobank, Am. J. Psychiatr., 20060947 Qi, 2020, Machine learning analysis of blood microRNA data in major depression: a case-control study for biomarker discovery, Int. J. Neuropsychopharmacol., 23, 505, 10.1093/ijnp/pyaa029 Roman, 2020, Novel neuroimmunologic therapeutics in depression: a clinical perspective on what we know so far, Brain Behav. Immun., 83, 7, 10.1016/j.bbi.2019.09.016 Rupprecht, 2010, Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders, Nat. Rev. Drug Discov., 9, 971, 10.1038/nrd3295 Rush, 2006, Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR∗D report, Am. J. Psychiatr., 163, 1905, 10.1176/ajp.2006.163.11.1905 Rush, 2006, Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression, N. Engl. J. Med., 354, 1231, 10.1056/NEJMoa052963 Sarubin, 2016, Translocator protein (TSPO) expression in platelets of depressed patients decreases during antidepressant therapy, Pharmacopsychiatry, 49, 204, 10.1055/s-0042-107795 Segman, 2010, Blood mononuclear cell gene expression signature of postpartum depression, Mol. Psychiatr., 15, 93, 10.1038/mp.2009.65 Sibille, 2006, SERT-ainly involved in depression, but when?, Am. J. Psychiatr., 163, 8, 10.1176/appi.ajp.163.1.8 Soczynska, 2012, Novel therapeutic targets in depression: minocycline as a candidate treatment, Behav. Brain Res., 235, 302, 10.1016/j.bbr.2012.07.026 Spijker, 2010, Stimulated gene expression profiles as a blood marker of major depressive disorder, Biol. Psychiatr., 68, 179, 10.1016/j.biopsych.2010.03.017 Sullivan, 2006, Evaluating the comparability of gene expression in blood and brain, Am J Med Genet B Neuropsychiatr Genet, 141b, 261, 10.1002/ajmg.b.30272 Tomita, 2004, Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain, Biol. Psychiatr., 55, 346, 10.1016/j.biopsych.2003.10.013 Trivedi, 2016, Right patient, right treatment, right time: biosignatures and precision medicine in depression, World Psychiatr., 15, 237, 10.1002/wps.20371 Uher, 2009, Genetic predictors of response to antidepressants in the GENDEP project, Pharmacogenomics J., 9, 225, 10.1038/tpj.2009.12 Uher, 2010, Genome-wide pharmacogenetics of antidepressant response in the GENDEP project, Am. J. Psychiatr., 167, 555, 10.1176/appi.ajp.2009.09070932 Yao, 2020, Translocator protein 18 kDa (TSPO) deficiency inhibits microglial activation and impairs mitochondrial function, Front. Pharmacol., 11 Zhao, 2020, A machine learning approach to identify a circulating MicroRNA signature for Alzheimer disease, The journal of applied laboratory medicine, 5, 15, 10.1373/jalm.2019.029595